Overt and 'subclinical' hypothyroidism in women

Obstetrical and Gynecological Survey

Volumn 61, Issue 8, 2006, Pages 535-542

  Wartofsky, Leonard ^a,b,c   Van Nostrand, Douglas ^a   Burman, Kenneth D ^a,b  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CARBONATE; CARBAMAZEPINE; COLESTIPOL; COLESTYRAMINE; CONTRAST MEDIUM; ESTROGEN; FERROUS SULFATE; LEVOTHYROXINE; LIOTHYRONINE; LIOTRIX; LITHIUM; PHENYTOIN; PROPYLTHIOURACIL; RALOXIFENE; SUCRALFATE; THYROID EXTRACT; THYROTROPIN; THYROXINE;

ATHEROGENESIS; CARDIOVASCULAR SYSTEM; CLINICAL FEATURE; DISEASE PREDISPOSITION; DYSLIPIDEMIA; HEART ARRHYTHMIA; HUMAN; HYPOTHYROIDISM; LABORATORY DIAGNOSIS; LIOTHYRONINE BLOOD LEVEL; LIPID ANALYSIS; METABOLISM; MORTALITY; OUTCOME ASSESSMENT; PREGNANCY; REVIEW; SCREENING; TACHYCARDIA; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME; UNITED STATES;

FEMALE; HASHIMOTO DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; PREGNANCY; PREGNANCY COMPLICATIONS; REFERENCE VALUES; THYROTROPIN; THYROXINE;

EID: 33746444362     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ogx.0000228778.95752.66     Document Type: Review

References (64)

1. Roos A, Linn-Rasker SP, van Domburg RT, et al. The starting dose of levothyroxine in primary hypothyroidism treatment. Arch Intern Med 2005;165:1714-1720.
2. Wartofsky L. Levothyroxine therapy for hypothyroidism: should we abandon conservative dosage titration? Arch Intern Med 2005;165:1683-1684.
3. Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004;351:241-249.
4. Diez JJ, Iglesias P, Burman KD. Normalization of thyrotropin concentrations in patients with spontaneous clinical hypothyroidism. J Clin Endocrinol Metab (in press).
5. Wilson GR, Curry RW Jr. Subclinical thyroid disease. Am Fam Physician 2005;72:1517-1524.
6. Cooper DS. Subclinical hypothyroidism. N Engl J Med 2001;345:260-265.
7. Ayala A, Wartofsky L. Minimally symptomatic (subclinical) hypothyroidism. Endocrinologist 1997;7:44-50.
8. Dickey RA, Wartofsky L, Feld S. Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid 2005;15:1035-1039.
9. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-499.
10. Baloch Z, Carayon P, Conte-Devolx B, et al. Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126.
11. Pinchera A. Subclinical thyroid disease: to treat or not to treat? Thyroid 2005;15:1-2.
12. Owen PJ, Lazarus JH. Subclinical hypothyroidism: the case for treatment. Trends Endocrinol Metab 2003;14:257-261.
13. Meier C, Staub J-J, Roth C-B, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001;86:4860-4866.
14. McDermott MT, Ridgway EC. Clinical perspective: subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab 2001;86:4585-4590.
15. Ayala A, Wartofsky L. The case for more aggressive screening and treatment of mild thyroid failure ('subclinical' hypothyroidism). Cleve Clin J Med 2002;69:313-320.
16. Chu JW, Crapo LM. Should mild hypothyroidism be treated? Am J Med 2002;112:422-423.
17. Chu JW, Crapo LM. The treatment of subclinical hypothyroidism is seldom necessary. J Clin Endocrinol Metab 2001;86:4591-4599.
18. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-238.
19. Gharib H, Tuttle RM, Baskin HJ, et al. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 2005;90:581-585.
20. Surks MI. Commentary: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 2005;90:586-587.
21. Ringel MD, Mazzaferri EL. Editorial: subclinical thyroid dysfunction - can there be a consensus about the consensus? J Clin Endocrinol Metab 2005;90:588-590.
22. Baskin HJ, Cobin RH, Duick DS, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Hyperthyroidism and Hypothyroidism. Endocr Pract 2002;8:457-469.
23. Alvarez-Marfany M, Roman SH, Drexler AJ, et al. Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1994;79:10-16.
24. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995;43:55-68.
25. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the 'euthyroid sick syndrome.' Endocr Rev 1982;3:164-216.
26. Bacci V, Schussler GC, Kaplan TB. The relationship between serum triiodothyronine and thyrotropin during systemic illness. J Clin Endocrinol Metab 1982;54:1229-1235.
27. Faber J, Petersen L, Wiinberg N, et al. Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. Thyroid 2002;12:319-324.
28. Monzani F, DiBello V, Caraccio N, et al. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab 2001;86:1110-1115.
29. Biondi B, Fazio S, Palmieri EA, et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1999;84:2064-2067.
30. DiBello V, Monzani F, Giorgi D, et al. Ultrasonic myocardial textural analysis in subclinical hypothyroidism. J Am Soc Echocardiogr 2000;13:832-840.
31. Lekakis J, Papamichael C, Alevizaki M, et al. Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin values. Thyroid 1997;7:411-414.
32. Taddei S, Caraccio N, Virdis A, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003;88:3731-3737.
33. Cooper DS, Halpern R, Wood LC, et al. L-thyroxine therapy in subclinical hypothyroidism. A double blind, placebo-controlled trial. Ann Intern Med 1984;101:18-24.
34. Monzani F, Caraccio N, Kozakowa M, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab 2004;89:2099-2106.
35. Hak AE, Pols HAP, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 2000;132:270-278.
36. Imaizumi M, Akahoshi M, Ichimaru S, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 2004;89:3365-3370.
37. Tuzcu A, Bahceci M, Gokalp D, et al. Subclinical hypothyroidism may be associated with elevated high sensitive C-reactive protein and fasting hyperinsulinemia. Endocr J 2005;52:89-94.
38. Redondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005;165:2460-2466.
39. Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 2005;165:2467-2472.
40. Nagasaki T, Inaba M, Kumeda Y, et al. Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab 2006;91:154-158.
41. Caraccio N, Farrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 2002;87:1533-1538.
42. Zoncu S, Pigliaru F, Putzu C, et al. Cardiac function in borderline hypothyroidism: a study by pulsed wave tissue Doppler imaging. Eur J Endocrinol 2005;152:527-533.
43. Brenta G, Mutti LA, Schnitman M, et al. Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to thyroxine therapy. Am J Cardiol 2003;91:1327-1330.
44. Caraccio N, Natali A, Sironi A, et al. Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine. J Clin Endocrinol Metab 2005;90:4057-4062.
45. Milionis HJ, Tambaki AP, Kanioglou CN, et al. Thyroid substitution therapy induces high density lipoprotein-associated platelet-activating factor acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect. Thyroid 2005;15:455-460.
46. Haggerty JJ Jr, Prange AL Jr. Borderline hypothyroidism and depression. Annu Rev Med 1995;46:37-46.
47. Haddow JE, Palomaki GE, Allan CW, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549-555.
48. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hypothyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 1994;130:350-356.
49. Stathatos N, Wartofsky L. Effects of thyroid hormone on bone. Clin Reviews Bone & Mineral Metabolism 2004;2:135-150.
50. Stockigt JR. Case finding and screening strategies for thyroid dysfunction. Clin Chim Acta 2002;315:111-124.
51. US Preventive Services Task Force. Screening for thyroid disease: recommendation statement. Ann Intern Med 2004;140:125-127.
52. Helfand M. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2004;140:128-141.
53. Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection thyroid dysfunction. Arch Intern Med 2000;160:1573-1575.
54. American Association of Clinical Endocrinologists. Clinical guidelines for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002;8:457-467.
55. American Academy of Family Physicians. Summary of Policy Recommendations for Periodic Health Examinations. Leawood, KS: American Academy of Family Physicians, 2002.
56. American College of Physicians. Clinical guideline. I. Screening for thyroid disease. Ann Intern Med 1998;129:141-143.
57. American College of Obstetrics and Gynecology. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 37. Obstet Gynecol 2002;100:387-396.
58. Lazarus JH, Premawardhana LD. Screening for thyroid disease in pregnancy. J Clin Pathol 2005;58:449-452.
59. Mitchell ML, Klein RZ. The sequelae of untreated maternal hypothyroidism. Eur J Endocrinol 2004;151:U45-U48.
60. Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol 1999;50:149-155.
61. Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2004;105:239-245.
62. Spong C. Subclinical hypothyroidism: should all pregnant women be screened? Obstet Gynecol 2005;105:235-236.
63. Danese M, Powe N, Sawin C, et al. Screening for mild thyroid failure at periodic examination. A decision and cost-effectiveness analysis. JAMA 1996;276:285-291.
64. Mandel SJ, Spencer CA, Hollowell JG. Are detection and treatment of thyroid insufficiency in pregnancy feasible? Thyroid 2005;15:44-53.